Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases.

Heath OM, van Beekhuizen HJ, Nama V, Kolomainen D, Nobbenhuis MA, Ind TE, Sohaib SA, Lofts FJ, Heenan S, Gore M, Banerjee S, Kaye SB, Barton DP.

Thromb Res. 2016 Jan;137:30-5. doi: 10.1016/j.thromres.2015.11.030. Epub 2015 Nov 22.

PMID:
26653367
2.
3.

Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.

Diaz ES, Walts AE, Karlan BY, Walsh CS.

Gynecol Oncol. 2013 Dec;131(3):541-5. doi: 10.1016/j.ygyno.2013.09.005. Epub 2013 Sep 14.

PMID:
24041880
4.

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B, Pfisterer J, Sehouli J; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

J Clin Oncol. 2008 Jun 1;26(16):2683-9. doi: 10.1200/JCO.2008.16.1109.

PMID:
18509180
5.

The survival detriment of venous thromboembolism with epithelial ovarian cancer.

Gunderson CC, Thomas ED, Slaughter KN, Farrell R, Ding K, Farris RE, Lauer JK, Perry LJ, McMeekin DS, Moore KN.

Gynecol Oncol. 2014 Jul;134(1):73-7. doi: 10.1016/j.ygyno.2014.04.046. Epub 2014 May 1.

PMID:
24793732
6.

Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).

Fotopoulou C, Karavas A, Trappe R, Chekerov R, Lichtenegger W, Sehouli J.

Thromb Res. 2009 Nov;124(5):531-5. doi: 10.1016/j.thromres.2009.03.013. Epub 2009 May 8.

PMID:
19427025
7.

Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.

Abu Saadeh F, Norris L, O'Toole S, Gleeson N.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):214-8. doi: 10.1016/j.ejogrb.2013.06.004. Epub 2013 Jul 2.

PMID:
23830352
8.

The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.

Yang Y, Zhang XZ, Ng HS, Fong JC, Lee LH.

Thromb Res. 2015 Sep;136(3):548-51. doi: 10.1016/j.thromres.2015.06.033. Epub 2015 Jul 6.

PMID:
26164397
9.

Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.

Zöller B, Palmer K, Li X, Sundquist J, Sundquist K.

Thromb Res. 2015 Sep;136(3):573-81. doi: 10.1016/j.thromres.2015.07.004. Epub 2015 Jul 14.

PMID:
26194121
10.

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman LD, Gabra H, Fotopoulou C, Sood AK.

Eur J Cancer. 2015 Sep;51(14):1978-88. doi: 10.1016/j.ejca.2015.07.012. Epub 2015 Jul 31.

11.

Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.

Tetsche MS, Nørgaard M, Pedersen L, Lash TL, Sørensen HT.

BMC Cancer. 2006 Jul 17;6:189.

12.

Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.

Rollins KE, Peters CJ, Safranek PM, Ford H, Baglin TP, Hardwick RH.

Eur J Surg Oncol. 2011 Dec;37(12):1072-7. doi: 10.1016/j.ejso.2011.08.140. Epub 2011 Sep 16.

PMID:
21925829
13.

Inferior vena cava filter placement and risk of hematogenous distant metastasis in ovarian cancer.

Matsuo K, Carter CM, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB.

Am J Clin Oncol. 2013 Aug;36(4):362-7. doi: 10.1097/COC.0b013e318248da32.

PMID:
22643565
14.

Epidemiology, risk and outcomes of venous thromboembolism in cancer.

Falanga A, Russo L.

Hamostaseologie. 2012;32(2):115-25. doi: 10.5482/ha-1170. Epub 2011 Oct 5. Review.

PMID:
21971578
15.

Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses.

Kumar A, Hurtt CC, Cliby WA, Martin JR, Weaver AL, McGree ME, Langstraat CL, Bakkum-Gamez JN.

Gynecol Oncol. 2017 Dec;147(3):514-520. doi: 10.1016/j.ygyno.2017.09.020. Epub 2017 Sep 22.

PMID:
28947173
16.

Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.

Park LC, Woo SY, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS.

Thromb Res. 2012 Sep;130(3):e6-12. doi: 10.1016/j.thromres.2012.03.019. Epub 2012 Apr 14.

PMID:
22507288
17.

Characteristic and prognostic implication of venous thromboembolism in ovarian clear cell carcinoma: a 12-year retrospective study.

Ye S, Yang J, Cao D, Bai H, Huang H, Wu M, Chen J, You Y, Lang J, Shen K.

PLoS One. 2015 Mar 20;10(3):e0121818. doi: 10.1371/journal.pone.0121818. eCollection 2015.

18.

Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.

Black D, Iasonos A, Ahmed H, Chi DS, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2007 Oct;107(1):66-70. Epub 2007 Jul 5.

PMID:
17614125
19.

Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.

Abu-Rustum NR, Richard S, Wilton A, Lev G, Sonoda Y, Hensley ML, Gemignani M, Barakat RR, Chi DS.

Gynecol Oncol. 2005 Nov;99(2):320-6. Epub 2005 Aug 2.

PMID:
16061278
20.

Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.

Moeini A, Machida H, Takiuchi T, Blake EA, Hom MS, Miki T, Matsuo O, Matsuo K.

Clin Appl Thromb Hemost. 2017 Nov;23(8):1018-1027. doi: 10.1177/1076029616665925. Epub 2016 Aug 31.

PMID:
27582024

Supplemental Content

Support Center